- Q1 2024 IMCD NV Earnings Call TranscriptApr 26, 2024€146.75 (-1.68%)Earnings
- Q3 2023 IMCD NV Earnings Call TranscriptNov 10, 2023€125.55 (+4.19%)Earnings
- Q2 2023 IMCD NV Earnings Call TranscriptAug 04, 2023€122.95 (-5.93%)Earnings
- Q1 2023 IMCD NV Earnings Call TranscriptApr 26, 2023€137.7 (-4.94%)Earnings
- Q4 2022 IMCD NV Earnings Call TranscriptFeb 24, 2023€141.5 (-3.74%)Earnings
- Q3 2022 IMCD NV Earnings Call TranscriptNov 10, 2022€139.85 (+5.27%)Earnings
- Q2 2022 IMCD NV Earnings Call TranscriptAug 04, 2022€154.1 (+1.58%)Earnings
- Q1 2022 IMCD NV Earnings Call TranscriptApr 29, 2022€153.25 (-0.87%)Earnings
- Q4 2021 IMCD NV Earnings Call TranscriptFeb 25, 2022€139.45 (+1.12%)Earnings
- Q3 2021 IMCD NV Earnings Call TranscriptNov 09, 2021€195.35 (-0.18%)Earnings
- Q2 2021 IMCD NV Earnings Call TranscriptAug 04, 2021€161.55 (+10.35%)Earnings
- Q1 2021 IMCD NV Earnings Call TranscriptApr 29, 2021€121.7 (-0.49%)Earnings
- Full Year 2020 IMCD NV Earnings Call TranscriptFeb 26, 2021€101.85 (-0.68%)Earnings
- Nine Months 2020 IMCD NV Earnings Call TranscriptNov 11, 2020€106.05 (+3.31%)Earnings
- IMCD N.V., Signet Excipients Private Limited - M&A Call TranscriptSep 15, 2020
- Half Year 2020 IMCD NV Earnings Call TranscriptAug 18, 2020€89.56 (-0.42%)Earnings
- Q1 2020 IMCD NV Trading Update Call TranscriptApr 20, 2020
- Full Year 2019 IMCD NV Earnings Call TranscriptFeb 27, 2020€75.95 (-0.20%)Earnings
- Nine Months 2019 IMCD NV Earnings Call TranscriptNov 12, 2019€72.75 (+1.11%)Earnings
- Half Year 2019 IMCD NV Earnings Call TranscriptAug 16, 2019€62.25 (-14.67%)Earnings
- Q1 2019 IMCD NV Earnings Call TranscriptMay 08, 2019€71.35 (+2.74%)Earnings
- Full Year 2018 IMCD NV Earnings Call TranscriptMar 01, 2019€67.4 (-2.18%)Earnings
Nine Months 2019 IMCD NV Earnings Call Transcript
Ladies and gentlemen, thank you for holding, and welcome to the IMCD analyst call third quarter results. (Operator Instructions)
I would like to hand over the conference to Mr. van der Slikke. Go ahead, please.
Yes. Good morning, everyone. I'm sitting here with Hans Kooijmans, a little bit in a different setting, as usual, because we are in a van in Paris. We departed from our hotel to the office and then -- 1.5 hours ago, and we're still not at the office. So we're calling you from the van, and I hope that the reception is okay. It could be that if we reach the office that we need to step out and put you on hold for a couple of minutes. But we felt that we should just start. So I will give a short introduction and then give over to Hans, as usual, to give us a comment on the numbers. And of course, after that, we are happy to answer your questions.
So we -- so you have seen the press release, and we are positive about the results of the first 9 months, with gross
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)